These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1200 related articles for article (PubMed ID: 28005230)

  • 1. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
    Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
    Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free-hand transperineal targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: single-center experience in China.
    Zhang Q; Wang W; Yang R; Zhang G; Zhang B; Li W; Huang H; Guo H
    Int Urol Nephrol; 2015 May; 47(5):727-33. PubMed ID: 25820744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
    Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
    BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
    Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
    BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance.
    Radtke JP; Kuru TH; Bonekamp D; Freitag MT; Wolf MB; Alt CD; Hatiboglu G; Boxler S; Pahernik S; Roth W; Roethke MC; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):283-91. PubMed ID: 27184812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer.
    Pepe P; Garufi A; Priolo G; Pennisi M
    Clin Genitourin Cancer; 2017 Feb; 15(1):e33-e36. PubMed ID: 27530436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate: an original technique with a good cancer detection rate.
    Wang L; Wang X; Zhao W; Zhao Z; Li Z; Fei S; Zhu H; Ji X; Yang B; Li N; Na Y
    BMC Urol; 2019 Nov; 19(1):107. PubMed ID: 31684917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies.
    Maxeiner A; Nest AM; Stephan C; Cash H; Baur ADJ; Fischer T; Kilic E; Piper SK; Nowak CP; Busch J; Miller K; Mang J
    Urol Int; 2020; 104(3-4):205-213. PubMed ID: 31801153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].
    Kesch C; Radtke JP; Distler F; Boxler S; Klein T; Hüttenbrink C; Hees K; Roth W; Roethke M; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Urologe A; 2016 Aug; 55(8):1071-7. PubMed ID: 27168038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer].
    Distler F; Radtke JP; Kesch C; Roethke M; Schlemmer HP; Roth W; Hohenfellner M; Hadaschik B
    Urologe A; 2016 Feb; 55(2):146-55. PubMed ID: 26556268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.
    von Below C; Wassberg C; Norberg M; Tolf A; Kullberg J; Ladjevardi S; Häggman M; Bill Axelson A; Ahlström H
    Scand J Urol; 2017 Apr; 51(2):107-113. PubMed ID: 28635568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
    Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
    Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
    Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G
    Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study.
    Junker D; Schäfer G; Heidegger I; Bektic J; Ladurner M; Jaschke W; Aigner F
    Urol Int; 2015; 94(3):313-8. PubMed ID: 25591786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy.
    Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Barbera M; Panella P; Pennisi M; Morgia G
    Arch Ital Urol Androl; 2016 Dec; 88(4):300-303. PubMed ID: 28073197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?
    Pepe P; Garufi A; Priolo G; Pennisi M
    World J Urol; 2016 Sep; 34(9):1249-53. PubMed ID: 26699628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers.
    Volkin D; Turkbey B; Hoang AN; Rais-Bahrami S; Yerram N; Walton-Diaz A; Nix JW; Wood BJ; Choyke PL; Pinto PA
    BJU Int; 2014 Dec; 114(6b):E43-E49. PubMed ID: 24712649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric MRI/TRUS Fusion Prostate Biopsy: Advantages of a Transperineal Approach.
    Pepe P; Garufi A; Priolo GD; Pennisi M
    Anticancer Res; 2017 Jun; 37(6):3291-3294. PubMed ID: 28551679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.